ÂÜÀòÂÒÂ×

Christopher Codeanne is the current Director at Strategikon Pharma. Prior to this, they were the Chief Financial Officer at Oxford Performance Materials, Inc. from July 2014 to February 2018.

OPM is a recognized leader in advanced materials science, founded in 2000 to exploit and commercialize the world’s highest performing thermoplastics. The company has three strategic business units: OPM Materials, OPM Aerospace & Industrial, and OPM Biomedical.

Codeanne was responsible for the financial management of the company, including overseeing the development of budgets, financial planning, and investment strategies. Christopher was instrumental in helping OPM obtain FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants, and helped grow the company into a recognized leader in the field of 3D printing.

Christopher Codeanne has a BS in Accounting from Fairfield University and an MBA in Finance from the University of Connecticut School of Business. Christopher is also a Certified Public Accountant.